1,697
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Multidisciplinary management and outcome in pancreatic cancer patients treated with high-intensity focused ultrasound

, , , , , , , , & show all
Pages 456-462 | Received 13 Feb 2020, Accepted 21 Apr 2020, Published online: 12 May 2020

References

  • Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med. 2014;371:1039–1049.
  • Carrato A, Falcone A, Ducreux M, et al. A systematic review of the burden of pancreatic cancer in Europe: real-world impact on survival, quality of life and costs. J Gastrointest Canc. 2015;46:201–211.
  • Sultana A, Smith CT, Cunningham D, et al. Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer. J Clin Oncol. 2007;25:2607–2615.
  • Marinova M, Wilhelm-Buchstab T, Strunk H. Advanced pancreatic cancer: high-intensity focused ultrasound (HIFU) and other local ablative therapies. Rofo. 2019;191:216–227.
  • Gao HF, Wang K, Meng ZQ, et al. High intensity focused ultrasound treatment for patients with local advanced pancreatic cancer. Hepatogastroenterology. 2013;60:1906–1910.
  • Sofuni A, Moriyasu F, Sano T, et al. The current potential of high-intensity focused ultrasound for pancreatic carcinoma. J Hepatobiliary Pancreat Sci. 2011;18:295–303.
  • Zhang L, Wang ZB. High-intensity focused ultrasound tumor ablation: review of ten years of clinical experience. Front Med China. 2010;4:294–302.
  • Marinova M, Huxold HC, Henseler J, et al. Clinical effectiveness and potential survival benefit of US-guided high-intensity focused ultrasound in patients with advanced pancreatic cancer. Ultraschall Med. ahead of print. 2019;40:625–637.
  • Marinova M, Rauch M, Mucke M, et al. High-intensity focused ultrasound (HIFU) for pancreatic carcinoma: evaluation of feasibility, reduction of tumour volume and pain intensity. Eur Radiol. 2016;26:4047–4056.
  • Marinova M, Strunk HM, Rauch M, et al. High-intensity focused ultrasound (HIFU) for tumor pain relief in inoperable pancreatic cancer: evaluation with the pain sensation scale (SES). Schmerz. 2017;31:31–39.
  • Strunk HM, Henseler J, Rauch M, et al. Clinical use of high-intensity focused ultrasound (HIFU) for tumor and pain reduction in advanced pancreatic cancer. Fortschr Röntgenstr. 2016;188:662–670.
  • De Hert S, Staender S, Fritsch G, et al. Pre-operative evaluation of adults undergoing elective noncardiac surgery: updated guideline from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2018;35:407–465.
  • Yao CL, Trinh T, Wong GT, et al. Anaesthesia for high intensity focused ultrasound (HIFU) therapy. Anaesthesia. 2008;63:865–872.
  • Vedie AL, Neuzillet C. Pancreatic cancer: best supportive care. Presse Med. 2019;48:e175–e185.
  • Vincent A, Herman J, Schulick R, Hruban RH, et al. Pancreatic cancer. Pancreatic Cancer. Lancet. 2011;378:607–620.
  • Ierardi AM, Lucchina N, Bacuzzi A, Marco de C, et al. Percutaneous ablation therapies of inoperable pancreatic cancer: a systematic review. Ann Gastroenterol. 2015;28:431–439.
  • Ierardi AM, Lucchina N, Petrillo M, et al. Systematic review of minimally invasive ablation treatment for locally advanced pancreatic cancer. Radiol Med. 2014;119:483–498.
  • Keane MG, Bramis K, Pereira SP, et al. Systematic review of novel ablative methods in locally advanced pancreatic cancer. World J Gastroenterol. 2014;20:2267–2278.
  • Hwang JH, Wang YN, Warren C, et al. Preclinical in vivo evaluation of an extracorporeal HIFU device for ablation of pancreatic tumors. Ultrasound Med Biol. 2009;35:967–975.
  • Hynynen K, Lulu BA. Hyperthermia in cancer treatment. Invest Radiol. 1990;25:824–834.
  • Hu Z, Yang XY, Liu Y, et al. Investigation of HIFU-induced anti-tumor immunity in a murine tumor model. J Transl Med. 2007;5:34.
  • Liu F, Hu Z, Qiu L, et al. Boosting high-intensity focused ultrasound-induced anti-tumor immunity using a sparse-scan strategy that can more effectively promote dendritic cell maturation. J Transl Med. 2010;8:7.
  • Wu F, Zhou L, Chen WR. Host antitumour immune responses to HIFU ablation. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology. North American Hyperthermia Group. 2007;23:165–171.
  • Dimitrov D, Andreev T, Feradova H, et al. Multimodality treatment by FOLFOX plus HIFU in a case of advanced pancreatic carcinoma. A case report. JOP: Journal of the Pancreas. 2015;16:66–69.
  • Wang K, Chen Z, Meng Z, et al. Analgesic effect of high intensity focused ultrasound therapy for unresectable pancreatic cancer. Int J Hyperthermia. 2011;27:101–107.
  • Wu F. Extracorporeal high intensity focused ultrasound in the treatment of patients with solid malignancy. Minim Invasive Ther Allied Technol. 2006;15:26–35.
  • Xiong LL, Hwang JH, Huang XB, et al. Early clinical experience using high intensity focused ultrasound for palliation of inoperable pancreatic cancer. JOP. 2009;10:123–129.
  • Boselli E, Daniela-Ionescu M, Begou G, et al. Prospective observational study of the non-invasive assessment of immediate postoperative pain using the analgesia/nociception index (ANI). Br J Anaesth. 2013;111:453–459.
  • Jeanne M, Clement C, De Jonckheere J, et al. Variations of the analgesia nociception index during general anaesthesia for laparoscopic abdominal surgery. J Clin Monit Comput. 2012;26:289–294.
  • Sung HY, Jung SE, Cho SH, et al. Long-term outcome of high-intensity focused ultrasound in advanced pancreatic cancer. Pancreas. 2011;40:1080–1086.
  • Law JA, Broemling N, Cooper RM, et al.; for the Canadian Airway Focus Group. The difficult airway with recommendations for management–part 1–difficult tracheal intubation encountered in an unconscious/induced patient. Can J Anesth/J Can Anesth. 2013;60:1089–1118.